U.S. markets open in 3 hours 8 minutes

NRx Pharmaceuticals, Inc. (NRXPW)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.7600-0.0900 (-4.86%)
At close: 04:00PM EST
1.7500 -0.01 (-0.57%)
After hours: 05:22PM EST
Sign in to post a message.
  • t
    +1; up to 31 Institutions.

    Whose shares did they get? A lot of fear out there.
  • L
    Long John Silver
    JJ on his way to the bank..
  • a
    all in
    Does anybody know how I convert my shares back into the same amount of money I had before investing in NRXP?
  • F
    Wow Javitt, that really can't have been your plan. The share price keeps falling. You should really do something about it and take the consensual path!
  • 7
    wow big sell at 3.5. someone knows something
  • F
    Hello Dr JJ.
    Time to settle something, don't you think ?
    Believe me or not, it's sad for everyone. For you, for your investors, for your collaboration partner (or former collaboration partner if you decide to pursue in this direction...) and their investors.
    Just an idea : agree mediation, make a common PR, and spread Aviptadil all around the world. We can do it, I have faith in science.
  • K
    As much as I want this dispute settled. Starting to seem like it won't happen. Gunna lose my money in NRXP I'm sure but atleast RLFTF will catapult me ahead even after NRXP losses lol
  • t
    From the former head developer of Israel's experimental vaccine:

    “The institute’s vaccine was very successful and even now it is being tested,” he said. “The latest testing shows it is also effective against the Omicron variant. The bureaucracy has failed us repeatedly.”

    I give Dr. Javitt credit for taking opportunities to take on medication development challenges, and working to bring them to market. The potential reward for even moderate success remains worth the risk for me. The market cap is ridiculously low, considering.

    What do you call that space between reality and potential? When it's all said and done, and the battle is over...I call that space 'disappointment'. Fortunately for those who remain invested, the battle is not over.
  • B
    Congratulations all! A new 52 week low
  • R
    Looks like $RLFTF lawsuit will be weighted more heavily.
  • E
    Up to 300,000 US deaths in next ~60 days per USA Today article on 1/18/2022

    Everyone deserves the right to live

    Aviptadil needed now

    900,000 doses of Aviptadil needed now just in the US and just for those at imminent risk of death

    That’s not counting another equal number in Europe

    And That’s not counting others who are also quite ill on oxygen as the virus wreaks havoc on their organs

    The world could easily use at least 4 million doses of Aviptadil over the next ~60 days (to treat at least 1.3M people globally)

    Hello medical establishment...

    Everyone deserves the right to live

    Aviptadil needed now
  • G
    There is hope! Dr Javitt is planning on taking credit and ownership of the Brilife vaccine. It will be patented under the name Javivax
  • w
    Relief Therapeutics attorneys are waiting for you, Javitt... $RLFTF
  • N
    I'm worried we have another denial and insiders are selling....
  • y
    What’s the record for how quickly a company lists on nasdaq then goes bankrupt? What about for companies with CEOs having majority shares?

    Looks like Nrxp is done this year or early next. Only hope is to get rid of Javitt, but he is not the type of individual to allow that to happen.
  • A
    I invested 80k in Relief and Nrx. And I'm now down to 14k. So much for pretty much all my savings. I had so much trust in the drug and most of all, in Javitt and his team. We took blow after blow and by the looks of it, we haven't even reached the bottom. It is hard to stay positive and remain invested...really hard 🥵🥵
  • B
    Hi, what are the chances you guys think NRXP will be able to get the EUA this time?
  • M
    It is poetic justice to think Javitt needs investment bankers like Ram and Weinstein the most right now to save his boat from capsizing. I used to think investment bankers could care less about us retail shareholders and were solely after dollar signs, and maybe to some extent they are, but Javitt and his team of beauracts have shown those whom enter government are far more power hungry.